A mouse model for monitoring islet cell genesis and developing therapies for diabetes
SUMMARY Transient expression of the transcription factor neurogenin-3 marks progenitor cells in the pancreas as they differentiate into islet cells. We developed a transgenic mouse line in which the surrogate markers secreted alkaline phosphatase (SeAP) and enhanced green florescent protein (EGFP) c...
Main Authors: | Yoshinori Shimajiri, Yasuhiro Kosaka, David W. Scheel, Francis C. Lynn, Nina Kishimoto, Juehu Wang, Shuhong Zhao, Michael S. German |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2011-03-01
|
Series: | Disease Models & Mechanisms |
Online Access: | http://dmm.biologists.org/content/4/2/268 |
Similar Items
-
Cell Therapy for Diabetes Using Piscine Islet Tissue
by: James R. Wright M.D., Ph.D., et al.
Published: (2001-03-01) -
Islet Transplantation & β-Cell Replacement Therapies for Diabetes
by: Thierry Berney, et al.
Published: (2011-01-01) -
Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation
by: Li Xin, et al.
Published: (2007-01-01) -
Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes.
by: German Kilimnik, et al.
Published: (2011-01-01) -
Roles of Islet Toll-Like Receptors in Pig to Mouse Islet Xenotransplantation
by: Han Ro, et al.
Published: (2013-09-01)